Developer docs
API playgroundTry for free, no card

Search company profiles

Agrivida

Full company profile

uuid00034x6

Namestring
Agrivida
Legal namestring
Agrivida, Inc.
Websiteurl
agrivida.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Agrivida is a privately held biotechnology company founded in 2002 by MIT scientists, headquartered in Woburn, Massachusetts, with a secondary office in North Platte, Nebraska. The company has developed the proprietary GRAINZYME platform, which produces animal feed enzymes directly inside corn kernels through a natural, identity-preserved process, eliminating the need for external fermentation-based enzyme manufacturing. GRAINZYME Phytase, the first commercial product, is a corn-based enzyme delivery system that replaces a small fraction of standard corn in finished feed (at a few pounds per ton) to deliver phytase and other beneficial enzymes to livestock, improving nutrient utilization, feed conversion, and reducing phosphorus and nitrogen excretion.

Agrivida's commercial focus is on livestock nutrition markets — initially poultry (commercial since November 2018) and swine (December 2019), with dairy, beef, and aquaculture identified as pipeline applications. The company sells GRAINZYME-powered corn directly to feed mills and livestock producers under a sales-led go-to-market motion, supplemented by a strategic partnership with Kerry Animal Health & Nutrition (announced November 2018) for joint commercialization. Revenue is generated through product sales of the enzyme-infused corn, though pricing is not publicly disclosed. The GRAINZYME platform also underpins a pipeline product, GRAINZYME NSP, targeting non-starch polysaccharide enzymes.

The company is venture-backed by a syndicate of leading ag-tech and generalist investors including ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Syngenta Ventures, Open Prairie Rural Opportunities Fund, Cultivian Sandbox Ventures, TechAccel, and others, with cumulative disclosed funding of approximately $80M+ across multiple rounds since inception. Agrivida achieved USDA deregulation of GRAINZYME Phytase in October 2021, a key regulatory milestone enabling full U.S. commercial deployment, and was recognized by Real Leaders as one of the 200 Top Impact Companies of 2022. The company employs 11–50 people and is led by Rajiv Singh as Interim CEO.

Short descriptiontext

Agrivida is a biotechnology company that produces animal feed enzymes directly inside corn kernels via its proprietary GRAINZYME platform, selling enzyme-infused corn to feed mills serving poultry, swine, dairy, beef, and aquaculture producers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWoburn, United States
HQ citystring
Woburn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal feed enzymes, enzyme feed additives, corn-based biotechnology, livestock nutrition, phytase production
Industry3 codes
1Corn (Maize) Farming
CodeAFAGAAABPrimaryYes
2Sweet Corn & Specialty Corn Farming (Fresh Market Corn, Baby Corn)
CodeAFAGADAHPrimaryNo
3Grain & Sugar-Based Ethanol Production
CodeEUAAAHAAPrimaryNo
NAICS code2 codes
  • Corn Farming111150
  • Corn Farming11115
SIC code2 codes
  • Agricultural Production-Crops100
  • Wholesale-Farm Product Raw Materials5150
Product category
Animal Feed Ingredients
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1GRAINZYME enzyme corn products
TypeHardware Sales
Description

Agrivida generates revenue by selling enzyme-infused corn (GRAINZYME corn) to feed mills and livestock producers. The corn replaces standard corn at a rate of a few pounds per ton of finished feed, delivering enzymes directly to livestock diets. Revenue is derived from product sales of phytase and other enzyme corn products to poultry, swine, dairy, beef, and aquaculture producers.

agrivida.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1GRAINZYME
Description

GRAINZYME technology is an innovative platform that produces enzymes inside a kernel of corn. It produces enzymes such as phytase, glucanase, and other enzymes that are introduced into animal diets by replacing a small amount of corn with GRAINZYME corn.

agrivida.com
Core offering1 text field

Agrivida produces enzyme-infused corn using its proprietary GRAINZYME technology platform, which grows enzymes such as phytase, glucanase, and other beneficial enzymes directly inside corn kernels rather than through external fermentation. The company sells GRAINZYME corn to feed mills and livestock producers (poultry, swine, dairy, beef, aquaculture), where it replaces a small amount of standard corn in finished feed to deliver dietary enzymes naturally and improve feed conversion efficiency.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Exceptional results demonstrated in over 50 million chickens
+2 more records
Product overview1 text field

Agrivida is a biotechnology company with GRAINZYME as its core technology platform. The platform produces various enzymes (phytase, glucanase, NSP enzymes, and others) directly inside corn kernels, offering a natural and simplified alternative to traditional enzyme fermentation and addition methods. GRAINZYME Phytase is the first commercial product, with GRAINZYME NSP and additional GRAINZYME-powered crops in the pipeline. Products serve poultry, swine, dairy, beef cattle, and aquaculture segments.

Product and service2 records
1GRAINZYME Phytase
CategoryAnimal Feed Enzymes
Description

Corn kernel-grown phytase enzyme that replaces a small amount of standard corn in finished feed to deliver dietary phytase to poultry and swine, improving nutrient utilization and reducing phosphorus excretion.

2GRAINZYME NSP
CategoryAnimal Feed Enzymes
Description

Non-Starch Polysaccharide (NSP) enzymes produced inside corn kernels using the GRAINZYME technology platform, intended for use in livestock feed applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-11-08
Description

Strategic partnership announced November 8, 2018 for joint commercialization and market development of GRAINZYME products in the animal nutrition sector.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2014-03-10
Description

Collaborative trait development agreement announced March 10, 2014 for successful genetic modification corn traits for improved dairy and beef nutrition.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in fermentation-derived feed enzymes (phytase, xylanase, proteases). Competes with GRAINZYME's in-kernel approach via incumbent fermentation supply chains serving the same feed-mill and livestock customers.

TypeBroad incumbent
Description

Major animal nutrition and feed additive company with extensive phytase and enzyme portfolio (e.g., Ronozyme). Competes in the same animal-feed enzyme market Agrivida targets with GRAINZYME.

TypeDirect peer
Description

Specialty producer of industrial enzymes including feed enzymes (phytase, xylanase). Directly competes with Agrivida in supplying feed-grade enzymes to livestock producers via feed mills.

TypeDirect peer
Description

Strategic commercialization partner of Agrivida (Nov 2018) and major animal nutrition ingredient supplier. Comparable as it serves the same feed-mill customers with enzyme and nutrition solutions, though via purchased/partnered products rather than in-kernel delivery.

TypeBroad incumbent
Description

Global animal nutrition specialist with feed enzymes (phytase/Rovabio) and specialty ingredients serving poultry and swine producers. Competes in the same animal-feed enzyme additive market.

TypeBroad incumbent
Description

Animal nutrition ingredient manufacturer producing feed enzymes and gut-health solutions for poultry, swine, and ruminants. Overlapping customer base and product positioning with Agrivida.

TypeBroad incumbent
Description

Animal health and nutrition company with feed additive portfolio including enzyme products. Serves similar livestock producer customers and competes for feed-mill shelf space.

TypeBroad incumbent
Description

Major animal health company with feed additives and nutritional health products across poultry, swine, and ruminants. Broader portfolio but overlapping customers and enzyme/nutrition product categories.

TypeEmerging player
Description

Emerging alternative-protein and specialty feed ingredient companies targeting animal nutrition with novel sustainable inputs. Comparable as innovative entrants addressing feed efficiency and sustainability—paralleling Agrivida's value proposition.

TypeEmerging player
Description

Gene-editing agriculture company developing specialty crop traits including for animal feed applications. Closely comparable technology approach—engineered crop traits for downstream agricultural use.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds18 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors29 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agrivida

Animal Feed Ingredientsagrivida.com

Agrivida is a biotechnology company that produces animal feed enzymes directly inside corn kernels via its proprietary GRAINZYME platform, selling enzyme-infused corn to feed mills serving poultry, swine, dairy, beef, and aquaculture producers.

What Agrivida does

Agrivida is a privately held biotechnology company founded in 2002 by MIT scientists, headquartered in Woburn, Massachusetts, with a secondary office in North Platte, Nebraska. The company has developed the proprietary GRAINZYME platform, which produces animal feed enzymes directly inside corn kernels through a natural, identity-preserved process, eliminating the need for external fermentation-based enzyme manufacturing. GRAINZYME Phytase, the first commercial product, is a corn-based enzyme delivery system that replaces a small fraction of standard corn in finished feed (at a few pounds per ton) to deliver phytase and other beneficial enzymes to livestock, improving nutrient utilization, feed conversion, and reducing phosphorus and nitrogen excretion.

Agrivida's commercial focus is on livestock nutrition markets — initially poultry (commercial since November 2018) and swine (December 2019), with dairy, beef, and aquaculture identified as pipeline applications. The company sells GRAINZYME-powered corn directly to feed mills and livestock producers under a sales-led go-to-market motion, supplemented by a strategic partnership with Kerry Animal Health & Nutrition (announced November 2018) for joint commercialization. Revenue is generated through product sales of the enzyme-infused corn, though pricing is not publicly disclosed. The GRAINZYME platform also underpins a pipeline product, GRAINZYME NSP, targeting non-starch polysaccharide enzymes.

The company is venture-backed by a syndicate of leading ag-tech and generalist investors including ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Syngenta Ventures, Open Prairie Rural Opportunities Fund, Cultivian Sandbox Ventures, TechAccel, and others, with cumulative disclosed funding of approximately $80M+ across multiple rounds since inception. Agrivida achieved USDA deregulation of GRAINZYME Phytase in October 2021, a key regulatory milestone enabling full U.S. commercial deployment, and was recognized by Real Leaders as one of the 200 Top Impact Companies of 2022. The company employs 11–50 people and is led by Rajiv Singh as Interim CEO.

Agrivida firmographics

Firmographics
Name
Agrivida
Legal name
Agrivida, Inc.
Website
https://agrivida.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Agrivida is a biotechnology company that produces animal feed enzymes directly inside corn kernels via its proprietary GRAINZYME platform, selling enzyme-infused corn to feed mills serving poultry, swine, dairy, beef, and aquaculture producers.
Ownership category
akta.pro rank

Agrivida industry classification

Industry
Product category
Animal Feed Ingredients
NAICS
Corn Farming (111150), Corn Farming (11115)
SIC
Agricultural Production-Crops (100), Wholesale-Farm Product Raw Materials (5150)
akta.pro primary industry
Corn (Maize) Farming (AFAGAAAB)
akta.pro secondary industries
Sweet Corn & Specialty Corn Farming (Fresh Market Corn, Baby Corn) (AFAGADAH), Grain & Sugar-Based Ethanol Production (EUAAAHAA)

Keywords

  • Animal feed enzymes
  • Enzyme feed additives
  • Corn-based biotechnology
  • Livestock nutrition
  • Phytase production

Where Agrivida is headquartered

Location

Headquarters

HQ city
Woburn
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Agrivida business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. GRAINZYME enzyme corn products: Agrivida generates revenue by selling enzyme-infused corn (GRAINZYME corn) to feed mills and livestock producers. The corn replaces standard corn at a rate of a few pounds per ton of finished feed, delivering enzymes directly to livestock diets. Revenue is derived from product sales of phytase and other enzyme corn products to poultry, swine, dairy, beef, and aquaculture producers.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Agrivida product offering

Product offering

Core offering

Agrivida produces enzyme-infused corn using its proprietary GRAINZYME technology platform, which grows enzymes such as phytase, glucanase, and other beneficial enzymes directly inside corn kernels rather than through external fermentation. The company sells GRAINZYME corn to feed mills and livestock producers (poultry, swine, dairy, beef, aquaculture), where it replaces a small amount of standard corn in finished feed to deliver dietary enzymes naturally and improve feed conversion efficiency.

Product overview

Agrivida is a biotechnology company with GRAINZYME as its core technology platform. The platform produces various enzymes (phytase, glucanase, NSP enzymes, and others) directly inside corn kernels, offering a natural and simplified alternative to traditional enzyme fermentation and addition methods. GRAINZYME Phytase is the first commercial product, with GRAINZYME NSP and additional GRAINZYME-powered crops in the pipeline. Products serve poultry, swine, dairy, beef cattle, and aquaculture segments.

Differentiator

Problem solved

Functional benefit

Brands

  • GRAINZYME: GRAINZYME technology is an innovative platform that produces enzymes inside a kernel of corn. It produces enzymes such as phytase, glucanase, and other enzymes that are introduced into animal diets by replacing a small amount of corn with GRAINZYME corn.

Products and services

  • GRAINZYME Phytase Corn kernel-grown phytase enzyme that replaces a small amount of standard corn in finished feed to deliver dietary phytase to poultry and swine, improving nutrient utilization and reducing phosphorus excretion.
  • GRAINZYME NSP Non-Starch Polysaccharide (NSP) enzymes produced inside corn kernels using the GRAINZYME technology platform, intended for use in livestock feed applications.

Quantifiable outcome

  • Exceptional results demonstrated in over 50 million chickens
  • +2 more outcomes

Companies that use Agrivida

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Agrivida technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Agrivida partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Kerry Animal Health & NutritioncoreStrategic or Co-development Partner · 8 November 2018Strategic partnership announced November 8, 2018 for joint commercialization and market development of GRAINZYME products in the animal nutrition sector.
  • Precision BioSciencesminorStrategic or Co-development Partner · 10 March 2014Collaborative trait development agreement announced March 10, 2014 for successful genetic modification corn traits for improved dairy and beef nutrition.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Agrivida competitors and assessment

Company assessment

Broad incumbents

  • Novonesis (formerly Novozymes): Global leader in fermentation-derived feed enzymes (phytase, xylanase, proteases). Competes with GRAINZYME's in-kernel approach via incumbent fermentation supply chains serving the same feed-mill and livestock customers.
  • dsm-firmenich (Animal Nutrition & Health): Major animal nutrition and feed additive company with extensive phytase and enzyme portfolio (e.g., Ronozyme). Competes in the same animal-feed enzyme market Agrivida targets with GRAINZYME.
  • Adisseo: Global animal nutrition specialist with feed enzymes (phytase/Rovabio) and specialty ingredients serving poultry and swine producers. Competes in the same animal-feed enzyme additive market.
  • Kemin Industries: Animal nutrition ingredient manufacturer producing feed enzymes and gut-health solutions for poultry, swine, and ruminants. Overlapping customer base and product positioning with Agrivida.
  • Phibro Animal Health: Animal health and nutrition company with feed additive portfolio including enzyme products. Serves similar livestock producer customers and competes for feed-mill shelf space.
  • Elanco Animal Health: Major animal health company with feed additives and nutritional health products across poultry, swine, and ruminants. Broader portfolio but overlapping customers and enzyme/nutrition product categories.

Direct peers

  • AB Enzymes: Specialty producer of industrial enzymes including feed enzymes (phytase, xylanase). Directly competes with Agrivida in supplying feed-grade enzymes to livestock producers via feed mills.
  • Kerry Group (Animal Health & Nutrition): Strategic commercialization partner of Agrivida (Nov 2018) and major animal nutrition ingredient supplier. Comparable as it serves the same feed-mill customers with enzyme and nutrition solutions, though via purchased/partnered products rather than in-kernel delivery.

Emerging players

  • Agriprotein / insect-based feed startups (e.g., InnovaFeed): Emerging alternative-protein and specialty feed ingredient companies targeting animal nutrition with novel sustainable inputs. Comparable as innovative entrants addressing feed efficiency and sustainability—paralleling Agrivida's value proposition.
  • Cibus: Gene-editing agriculture company developing specialty crop traits including for animal feed applications. Closely comparable technology approach—engineered crop traits for downstream agricultural use.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Agrivida social profiles

Digital presence

Agrivida financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agrivida leadership team

Management profile

Number of profiles

Profiles6 records

Agrivida funding detail

Funding detail

Funding overview

Funding rounds18 records

Investors29 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agrivida M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agrivida

What does Agrivida do?

Agrivida produces enzyme-infused corn using its proprietary GRAINZYME technology platform, which grows enzymes such as phytase, glucanase, and other beneficial enzymes directly inside corn kernels rather than through external fermentation. The company sells GRAINZYME corn to feed mills and livestock producers (poultry, swine, dairy, beef, aquaculture), where it replaces a small amount of standard corn in finished feed to deliver dietary enzymes naturally and improve feed conversion efficiency.

Is Agrivida a public or private company?

Agrivida is a private company. It is classified as venture growth investor backed and is currently operating.

When was Agrivida founded?

Agrivida was founded in 2003. It employs 11 to 50 people.

Where is Agrivida based?

Agrivida is headquartered in Woburn, United States, in the North America region.

How does Agrivida make money?

One revenue line is on record: GRAINZYME enzyme corn products.

Who are Agrivida's main competitors?

Broad incumbents on record are Novonesis (formerly Novozymes), dsm-firmenich (Animal Nutrition & Health), Adisseo, Kemin Industries, Phibro Animal Health and Elanco Animal Health. Direct peers are AB Enzymes and Kerry Group (Animal Health & Nutrition). Emerging players are Agriprotein / insect-based feed startups (e.g., InnovaFeed) and Cibus.

Does Agrivida have an API?

No public API is recorded for Agrivida.

What industry is Agrivida in?

Agrivida's product category is Animal Feed Ingredients. Its primary akta.pro industry code is AFAGAAAB, Corn (Maize) Farming, with a secondary code of AFAGADAH, Sweet Corn & Specialty Corn Farming (Fresh Market Corn, Baby Corn). Its NAICS code is 111150 and its SIC code is 100.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comCompetitive Landscape: Leading Companies and Rising Contenders in the Veterinary Intravenous (IV) Solutions MarketThe veterinary intravenous solutions market is projected to reach $2.36 billion by 2030, growing at a compound annual growth rate of 7.7%, driven by increasing demand for specialized fluid therapy products and expanding veterinary emergency and critical care services. The market overview highlights key trends including the development of advanced isotonic and balanced electrolyte solutions, greater adoption of parenteral nutrition, and a shift toward pre-mixed ready-to-use IV products. Notable recent developments include Novus International Inc.'s acquisition of Agrivida Inc. in January 2024 and Elanco Animal Health's April 2024 launch of Pradalex, an FDA-approved fluoroquinolone injection for treating swine respiratory disease.PR NewswireAgrivida Announces Availability Of GRAINZYME® Phytase For Swine OperationsAgrivida, a privately held biotechnology company headquartered in Woburn, Massachusetts, announced the availability of its GRAINZYME Phytase enzyme feed additive for swine operations following receipt of GRAS status from the U.S. Food and Drug Administration. The corn-based enzyme, already proven in over 50 million chickens, requires only 2 to 4 pounds per ton of feed to deliver phytase and nutrient credits, offering improved nutrition and feed conversion for swine producers. The Maschhoffs, the largest family-owned pig producer in North America, will conduct commercial evaluation of the product at scale, with Agrivida planning additional research across thousands of pigs from grower through finisher stages.PR NewswireAgrivida Announces Interim CEOAgrivida, a privately held biotechnology company based in Woburn, Massachusetts, announced the appointment of board member Rajiv Singh as interim CEO following the departure of Dan Meagher, who is leaving to take an executive position with a global animal health and nutrition company. During Meagher's five-year tenure, the company commercialized its GRAINZYME Phytase enzyme for poultry feeds, received FDA-CVM GRAS status for swine applications, and developed an NSP enzyme expected to launch in 2020. Singh, who has invested in the company and recently joined the board, will lead the company's transition from an R&D foundation to a commercial operation.VC News DailyAgrivida Secures $8MAgrivida has secured an $8 million first close in its financing round, led by Open Prairie Rural Opportunities Fund with participation from existing investors. The funding will support the expansion of Agrivida's research and development platform and the commercialization of its GRAINZYME Phytase technology into global poultry and swine markets.FinSMEsAgrivida Raises $20M in FinancingAgrivida raised $11M in the first tranche of a $20M financing round led by Open Prairie Rural Opportunities Fund. The funds will support R&D and commercialization of its GRAINZYME Phytase technology in poultry and swine markets.PR NewswireAgrivida Launches $20 Million Financing Round with Lead Investment from the Open Prairie Rural Opportunities FundThe Open Prairie Rural Opportunities Fund has led an $8 million first close in Agrivida's $20 million financing round, joining existing investors such as Syngenta Ventures and ARCH Venture Partners. This capital will support the expansion of Agrivida's research platform and the commercialization of its GRAINZYME® Phytase technology in global poultry and swine markets. The funding follows recent milestones including FDA approval for the product's sale in the US swine market.VC News DailyAgrivida Closes $23M in Series DAgrivida, Inc., a Medford, Massachusetts-based animal nutrition technology company, completed a $23 million Series D financing round led by Cultivian Sandbox Ventures with participation from ARCH Venture Partners, Maschhoff Family Foods, Middleland Capital and existing investors. The funding will advance development and commercialization of its GraINzyme feed additive enzymes and INergy silage technology platforms, with first commercial products targeted for 2016. The company positions its technology as a potentially disruptive solution in the feed enzyme market, using corn plants as bio-factories to produce enzymes at lower cost with reduced carbon footprint.VC News DailyAgrivida Raises $12M in Series DAgrivida, a Medford, Massachusetts-based technology company focused on animal nutrition, has raised $12 million in Series D financing led by Cultivian Sandbox Ventures. The funding will support the advancement and commercialization of the company's proprietary GraINzyme feed additive enzymes and INergy silage technology platforms. Additional investors included Kleiner Perkins Caufield & Byers, Middleland Capital, DAG Ventures, Bright Capital Partners, and others, with participation from an affiliate of Maschhoff Family Foods and the Sontag Family Trust.